Desq Long
Sign in

Company

Protagonist Therapeutics, Inc

PTGX · CIK 0001377121

SEC FORM 4
$157,059.24

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 7,278 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Sep 10, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,048,759.80

Protagonist Therapeutics, Inc (PTGX)

Sale of 7,278 shares at $144.10 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,371,365.84

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 63,548 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$9,289,446.64

Protagonist Therapeutics, Inc (PTGX)

Sale of 63,548 shares at $146.18 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,169,074.92

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 54,174 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$7,902,361.38

Protagonist Therapeutics, Inc (PTGX)

Sale of 54,174 shares at $145.87 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$738,877.62

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 34,239 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →

SEC FORM 4
$5,085,176.28

Protagonist Therapeutics, Inc (PTGX)

Sale of 34,239 shares at $148.52 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,419,122.38

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 65,761 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →

SEC FORM 4
$9,805,622.71

Protagonist Therapeutics, Inc (PTGX)

Sale of 65,761 shares at $149.11 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →